Managing Overweight and Obesity in Adults to Reduce Cardiovascular Disease Risk
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing Overweight and Obesity in Adults to Reduce Cardiovascular Disease Risk
Authors
Keywords
Anti-obesity agents, Bariatric surgery, Cardiovascular diseases, Obesity, Overweight, Practice guidelines
Journal
Current Atherosclerosis Reports
Volume 16, Issue 10, Pages -
Publisher
Springer Nature
Online
2014-08-04
DOI
10.1007/s11883-014-0445-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Obesity Guidelines
- (2014) Michael D. Jensen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
- (2014) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Obesity Agents: Lorcaserin and Phentermine/Topiramate
- (2013) Joshua W Fleming et al. ANNALS OF PHARMACOTHERAPY
- Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia
- (2013) Sayeed Ikramuddin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
- (2012) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus
- (2010) ARCHIVES OF INTERNAL MEDICINE
- Pharmacologic Therapies for Obesity
- (2010) Lee M. Kaplan GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
- (2008) W. J. Thomsen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Serotonin 5-HT2CReceptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors
- (2007) Daniel D. Lam et al. ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now